Latest news
Loading news…
Horizon Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Northbrook, Illinois, United States Founded 2005 1001-5000 employees For Profit
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Horizon Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Horizon Pharma was acquired by Amgen in 2022 for $27.8B.
Total Funding
$4.04B
Funding Rounds
14
Last Funding
Acquisitions
7
Monthly Visits
Contacts
2,523
About Horizon Pharma
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- HZNP
- Exchange
- NASDAQ
- IPO date
- Jul 28, 2011
- Raised at IPO
- $49.5M
- Valuation at IPO
- $175.68M
- Delisted
- Oct 6, 2023
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Active products
- 22
- IT spend
- $8.82M
Company Info
- Founded
- 2005
- Employees
- 1001-5000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 1
- News articles
- 293
- HQ
- Northbrook, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
- Exit date
- Jul 28, 2011
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0.6
- Trend (30d)
- 0
- Trend (90d)
- -1
- Last leadership hire
- Feb 16, 2022
Horizon Pharma Funding Rounds
14 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–5 of 14Show
Page 1 / 3
Horizon Pharma Acquisitions
7 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viela Bio | $3.05B | 2021-02-01 | Horizon Pharma | Acquisition | Cash | BiopharmaBiotechnologyHealth DiagnosticsMedicalWellness | Gaithersburg | United States | Viela Bio is a clinical-stage biotechnology company pioneeri… | 2017-01-01 | 101-250 | BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | United States | 1001-5000 | Delisted | 7 | vielabio.com/ | |
| Curzion Pharmaceuticals | — | 2020-04-02 | Horizon Pharma | Acquisition | — | BiotechnologyHealth CarePharmaceutical | San Diego | United States | Curzion Pharmaceuticals is a privately held development-stag… | 2019-01-01 | 1-10 | BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | United States | 1001-5000 | Delisted | 7 | — | |
| River Vision Development | $145M | 2017-05-08 | Horizon Pharma | Acquisition | Cash | Health CareTherapeuticsWellness | New York | United States | River Vision Development develops a protein therapy for the … | — | — | BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | United States | 1001-5000 | Delisted | 7 | — | |
| Raptor Pharmaceuticals | $800M | 2016-09-12 | Horizon Pharma | Acquisition | — | BiopharmaBiotechnologyGeneticsTherapeutics | Novato | United States | Raptor is a NASDAQ-listed biopharmaceutical company with the… | 2002-04-01 | 51-100 | BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | United States | 1001-5000 | Delisted | 7 | www.raptorpharma.com | |
| Hyperion Therapeutics | $1.1B | 2015-03-30 | Horizon Pharma | Acquisition | Cash | BiopharmaBiotechnologyHealth CareTherapeutics | South San Francisco | United States | Hyperion Therapeutics is a biopharmaceutical company focused… | — | — | BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics | United States | 1001-5000 | Delisted | 7 | www.hyperiontx.com |
1–5 of 7Show
Page 1 / 2
Horizon Pharma Key People
Senior Vice President, Marketing & Commercial Analytics
Senior Vice President, Clinical Development and Operations
Executive Vice President and Chief Financial Officer
Board of Directors
Executive Vice President, Medical Affairs and Outcomes Research
Senior Director, Health and Reimbursement Policy
SVP, Alliances & International Business Development
Board of Directors
Executive Vice President, Corporate Affairs and Chief Communications Officer
EVP & General Counsel
Senior Vice President, Global Manufacturing Operations
Director, Market Access
2,523
professional contacts at Horizon Pharma
Contact execs at Horizon Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Horizon Pharma
Loading news…
FAQs about Horizon Pharma
People who checked this page also checked these
Sectors Horizon Pharma invests & acquires in
Browse the full Acquirezy directory.